AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

OFIX · NASDAQ · Medical - Devices

Orthofix Medical (OFIX)

Builds spine implants, biologics, bone-growth therapies and limb-reconstruction systems.

$9.10

vs last close+0.12 (+1.29%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	184	200	189	199	197	216	194	203	206	220	197	211
Cost of revenue	64	64	61	64	62	67	72	64	57	78	57	61
Gross profit	120	137	127	135	135	149	122	140	149	142	140	150
	144	155	157	160	154	160	170	156	166	129	153	158
Research & development	19	19	19	18	17	19	20	16	15	15	15	16
	122	132	132	134	130	136	133	136	148	137	135	0
Selling & marketing	95	98	100	100	97	0	0	0	0	0	0	0
General & administrative	27	35	32	34	34	0	0	0	0	0	0	0
Other expenses	4	4	5	7	7	5	18	3	3	−24	3	142
Operating income	−24	−18	−29	−25	−19	−11	−49	−16	−17	13	−14	−8
	−4	−4	−6	−7	−8	−18	−3	2	−5	−16	−7	−7
Interest expense	2	5	5	5	5	15	5	4	5	4	6	6
Other non-operating income	2	−1	1	3	3	3	−1	−6	1	11	1	−1
Income before tax	−28	−22	−35	−32	−27	−30	−52	−14	−22	−2	−21	−15
Income tax expense	0	0	1	1	1	−1	1	0	1	0	0	1
Net income from continuing operations	−29	−22	−36	−33	−27	−29	−53	−14	−23	−2	−21	−16
Net income	−29	−22	−36	−33	−27	−29	−53	−14	−23	−2	−21	−16
EPS, basic	−$0.77	−$0.60	−$0.95	−$0.88	−$0.71	−$0.75	−$1.35	−$0.36	−$0.57	−$0.06	−$0.52	−$0.39
EPS, diluted	−$0.77	−$0.60	−$0.95	−$0.88	−$0.71	−$0.75	−$1.35	−$0.36	−$0.57	−$0.06	−$0.52	−$0.39
Weighted average shares, basic	37	37	38	38	38	39	39	40	40	40	40	41
Weighted average shares, diluted	37	37	38	38	38	39	39	40	40	40	40	41
EBITDA	−13	−1	−14	−12	−5	13	−12	8	−3	92	−2	20
Depreciation & amortization	14	17	16	16	17	27	36	18	15	89	13	28
EBIT	−27	−18	−31	−27	−21	−15	−48	−10	−18	2	−15	−7